High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells - PubMed (original) (raw)
High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells
R Bacchetta et al. J Exp Med. 1994.
Abstract
Transplantation of HLA mismatched hematopoietic stem cells in patients with severe combined immunodeficiency (SCID) can result in a selective engraftment of T cells of donor origin with complete immunologic reconstitution and in vivo tolerance. The latter may occur in the absence of clonal deletion of donor T lymphocytes able to recognize the host HLA antigens. The activity of these host-reactive T cells is suppressed in vivo, since no graft-vs. -host disease is observed in these human chimeras. Here it is shown that the CD4+ host-reactive T cell clones isolated from a SCID patient transplanted with fetal liver stem cells produce unusually high quantities of interleukin 10 (IL-10) and very low amounts of IL-2 after antigen-specific stimulation in vitro. The specific proliferative responses of the host-reactive T cell clones were considerably enhanced in the presence of neutralizing concentrations of an anti-IL-10 monoclonal antibody, suggesting that high levels of endogenous IL-10 suppress the activity of these cells. These in vitro data correlate with observations made in vivo. Semi-quantitative polymerase chain reaction analysis carried out on freshly isolated peripheral blood mononuclear cells (PBMC) of the patient indicated that the levels of IL-10 messenger RNA (mRNA) expression were strongly enhanced, whereas IL-2 mRNA expression was much lower than that in PBMC of healthy donors. In vivo IL-10 mRNA expression was not only high in the T cells, but also in the non-T cell fraction, indicating that host cells also contributed to the high levels of IL-10 in vivo. Patient-derived monocytes were found to be major IL-10 producers. Although no circulating IL-10 could be detected, freshly isolated monocytes of the patient showed a reduced expression of class II HLA antigens. However, their capacity to stimulate T cells of normal donors in primary mixed lymphocyte cultures was within the normal range. Interestingly, similar high in vivo IL-10 mRNA expressions in the T and non-T cell compartment were also observed in three SCID patients transplanted with fetal liver stem cells and in four SCID patients transplanted with T cell-depleted haploidentical bone marrow stem cells. Taken together, these data indicate that high endogenous IL-10 production is a general phenomenon in SCID patients in whom allogenic stem cell transplantation results in immunologic reconstitution and induction of tolerance. Both donor T cells and host accessory cells contribute to these high levels of IL-10, which would suppress the activity of host-reactive T cell in vivo.
Similar articles
- T cell repertoire and tolerance after fetal stem cell transplantation.
Roncarolo MG, Bacchetta R. Roncarolo MG, et al. Bone Marrow Transplant. 1992;9 Suppl 1:127-8. Bone Marrow Transplant. 1992. PMID: 1354521 - A SCID patient reconstituted with HLA-incompatible fetal stem cells as a model for studying transplantation tolerance.
Roncarolo MG, Bacchetta R, Bigler M, Touraine JL, de Vries JE, Spits H. Roncarolo MG, et al. Blood Cells. 1991;17(2):391-402. Blood Cells. 1991. PMID: 1680508 - [Transplantation of genetically modified cells in the treatment of children with SCID: great hopes and recent disappointments].
Smogorzewska EM, Weinberg KI, Kohn DB. Smogorzewska EM, et al. Med Wieku Rozwoj. 2003 Jan-Mar;7(1):27-34. Med Wieku Rozwoj. 2003. PMID: 13130167 Review. Polish. - HLA-haploidentical donor transplantation in severe combined immunodeficiency.
Friedrich W, Hönig M. Friedrich W, et al. Immunol Allergy Clin North Am. 2010 Feb;30(1):31-44. doi: 10.1016/j.iac.2009.11.004. Immunol Allergy Clin North Am. 2010. PMID: 20113885 Review.
Cited by
- The role of CD4 T cells in the pathogenesis of multiple sclerosis.
Chitnis T. Chitnis T. Int Rev Neurobiol. 2007;79:43-72. doi: 10.1016/S0074-7742(07)79003-7. Int Rev Neurobiol. 2007. PMID: 17531837 Free PMC article. Review. - Regulatory function of in vivo anergized CD4(+) T cells.
Jooss K, Gjata B, Danos O, von Boehmer H, Sarukhan A. Jooss K, et al. Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8738-43. doi: 10.1073/pnas.151088898. Epub 2001 Jul 3. Proc Natl Acad Sci U S A. 2001. PMID: 11438696 Free PMC article. - Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo.
Furukawa Y, Becker G, Stinn JL, Shimizu K, Libby P, Mitchell RN. Furukawa Y, et al. Am J Pathol. 1999 Dec;155(6):1929-39. doi: 10.1016/S0002-9440(10)65512-5. Am J Pathol. 1999. PMID: 10595923 Free PMC article. - CD4 T-Cell Subsets and the Pathophysiology of Inflammatory Bowel Disease.
Gomez-Bris R, Saez A, Herrero-Fernandez B, Rius C, Sanchez-Martinez H, Gonzalez-Granado JM. Gomez-Bris R, et al. Int J Mol Sci. 2023 Jan 31;24(3):2696. doi: 10.3390/ijms24032696. Int J Mol Sci. 2023. PMID: 36769019 Free PMC article. Review. - OX40 ligand shuts down IL-10-producing regulatory T cells.
Ito T, Wang YH, Duramad O, Hanabuchi S, Perng OA, Gilliet M, Qin FX, Liu YJ. Ito T, et al. Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13138-43. doi: 10.1073/pnas.0603107103. Epub 2006 Aug 21. Proc Natl Acad Sci U S A. 2006. PMID: 16924108 Free PMC article.
References
- Curr Opin Immunol. 1992 Apr;4(2):211-5 - PubMed
- Immunology. 1988 Jul;64(3):413-7 - PubMed
- J Immunol. 1992 Oct 1;149(7):2378-84 - PubMed
- Curr Opin Immunol. 1992 Jun;4(3):314-20 - PubMed
- Blood. 1992 Dec 15;80(12):2964-8 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials